BETHESDA, MD – RegeneRx, a biopharmaceutical company developing treatments to accelerate organ and tissue repair, has raised $3 million via a stock sale to affiliates of its largest shareholder, Sigma-Tau Group.

The company sold about 2.1 million shares at $1.45 a share.

The company says it will use the money to fund clinical trials and as working capital.

On the Web: www.regenerx.com

Southeast Venture Conference, February 29 – March 1, 2012 at the Ritz Carlton in Tysons Corner, VA – Where Smart Money Meets Smart People.
www.seventure.org

© 2008, TechJournal South. All rights reserved.